Insider Ownership
| Role | Insider | Shares | Value | 30d |
|---|
| ? | Roivant Sciences Ltd. | 113.32M | $2.49B | - |
| 10% | | 37.28M | $820.25M | - |
| 10% | Ramaswamy Vivek | 34.49M | $758.70M | - |
| Pres | Sukhatme Mayukh | 21.29M | $468.30M | -1,018,995 |
| ? | | 18.50M | $406.95M | - |
Transactions
50 transactions · page 5
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|
| 2022-11-10 | MANCHESTER KEITH S | Director | Sell | 2,311,643 | $4.75 | $10,980,304.25 | -7.6% | → |
| 2022-10-25 | Gline Matthew | CEO | Sell | 19,276 | $4.40 | $84,814.40 | -1.6% | → |
| 2022-10-25 | Kumar Rakhi | Chief Accounting Officer | Sell | 1,588 | $4.40 | $6,987.20 | -1.1% | → |
| 2022-10-25 | Venker Eric | President & COO | Sell | 15,922 | $4.40 | $70,056.80 | -1.5% | → |
| 2022-10-06 | Roivant Sciences Ltd. | - | Buy | 416,667 | $6.00 | $2,500,002.00 | +0.6% | → |
| 2022-09-23 | Kumar Rakhi | Chief Accounting Officer | Sell | 1,741 | $3.07 | $5,344.87 | -1.2% | → |
| 2022-09-23 | Venker Eric | President & COO | Sell | 17,392 | $3.07 | $53,393.44 | -1.6% | → |
| 2022-09-23 | Gline Matthew | CEO | Sell | 21,053 | $3.07 | $64,632.71 | -1.7% | → |
| 2022-08-24 | Kumar Rakhi | Chief Accounting Officer | Sell | 1,652 | $3.71 | $6,128.92 | -1.1% | → |
| 2022-08-24 | Venker Eric | President & COO | Sell | 16,530 | $3.71 | $61,326.30 | -1.5% | → |
| 2022-08-24 | Gline Matthew | CEO | Sell | 20,009 | $3.71 | $74,233.39 | -1.6% | → |
| 2022-07-25 | Kumar Rakhi | Chief Accounting Officer | Sell | 1,686 | $4.33 | $7,300.38 | -1.2% | → |
| 2022-07-25 | Gline Matthew | CEO | Sell | 20,455 | $4.33 | $88,570.15 | -1.6% | → |
| 2022-07-25 | Venker Eric | President & COO | Sell | 16,896 | $4.33 | $73,159.68 | -1.5% | → |
| 2022-06-23 | Kumar Rakhi | Chief Accounting Officer | Sell | 1,635 | $4.34 | $7,095.90 | -1.1% | → |
| 2022-06-23 | Gline Matthew | CEO | Sell | 19,855 | $4.34 | $86,170.70 | -1.6% | → |
| 2022-06-23 | Venker Eric | President & COO | Sell | 16,402 | $4.34 | $71,184.68 | -1.4% | → |
| 2022-05-20 | Gline Matthew | CEO | Sell | 139,791 | $3.70 | $517,226.70 | -10.0% | → |
| 2022-05-20 | Venker Eric | President & COO | Sell | 136,421 | $3.70 | $504,757.70 | -10.7% | → |
| 2022-05-20 | Kumar Rakhi | Chief Accounting Officer | Sell | 12,127 | $3.70 | $44,869.90 | -7.6% | → |
| 2022-04-25 | Kumar Rakhi | Chief Accounting Officer | Sell | 703 | $3.84 | $2,699.52 | -0.4% | → |
| 2022-04-25 | Venker Eric | President & COO | Sell | 5,107 | $3.84 | $19,610.88 | -0.4% | → |
| 2022-04-25 | Gline Matthew | CEO | Sell | 8,509 | $3.84 | $32,674.56 | -0.6% | → |
| 2022-04-25 | Dexcel Pharma Technologies Ltd. | - | Buy | 40,285 | $3.85 | $154,954.16 | - | → |
| 2022-03-30 | Kumar Rakhi | Chief Accounting Officer | Sell | 2,486 | $4.84 | $12,032.24 | -1.5% | → |
| 2022-03-30 | Gline Matthew | CEO | Sell | 33,686 | $4.84 | $163,040.24 | -2.3% | → |
| 2022-03-30 | Venker Eric | President & COO | Sell | 19,336 | $4.84 | $93,586.24 | -1.5% | → |
| 2022-03-25 | Venker Eric | President & COO | Sell | 80,045 | $5.06 | $405,027.70 | -5.8% | → |
| 2022-03-25 | Gline Matthew | CEO | Sell | 35,386 | $5.06 | $179,053.16 | -2.3% | → |
| 2022-03-25 | Kumar Rakhi | Chief Accounting Officer | Sell | 7,281 | $5.06 | $36,841.86 | -4.2% | → |
| 2022-03-18 | Kumar Rakhi | Chief Accounting Officer | Sell | 2,153 | $5.13 | $11,044.89 | -1.2% | → |
| 2022-03-18 | Gline Matthew | CEO | Sell | 82,006 | $5.13 | $420,690.78 | -5.2% | → |
| 2022-03-07 | Kumar Rakhi | Chief Accounting Officer | Sell | 3,091 | $5.52 | $17,062.32 | -1.7% | → |
| 2022-03-07 | Gline Matthew | CEO | Sell | 92,324 | $5.52 | $509,628.48 | -5.5% | → |
| 2020-09-04 | Roivant Sciences Ltd. | 10% Owner | Buy | 380,000 | $33.00 | $12,540,000.00 | +0.8% | → |
| 2020-04-16 | Roivant Sciences Ltd. | 10% Owner | Buy | 1,034,483 | $14.50 | $15,000,003.50 | +2.8% | → |
| 2020-02-24 | Roivant Sciences Ltd. | 10% Owner | Buy | 5,333,333 | $3.75 | $19,999,998.75 | +40.3% | → |
| 2019-12-27 | Roivant Sciences Ltd. | 10% Owner | Sell | 22,860,013 | $0.00 | - | -100% | → |
| 2019-12-27 | Roivant Sciences Ltd. | 10% Owner | Sell | 45,008,604 | $0.00 | - | -100% | → |
| 2019-12-17 | Roivant Sciences Ltd. | 10% Owner | Buy | 245,000 | $15.38 | $3,767,705.89 | +0.2% | → |
| 2019-12-04 | Roivant Sciences Ltd. | 10% Owner | Buy | 254,193 | $18.03 | $4,584,355.61 | +0.1% | → |
| 2019-11-25 | Roivant Sciences Ltd. | 10% Owner | Buy | 3,500,000 | $15.00 | $52,500,000.00 | +8.5% | → |
| 2019-11-21 | Roivant Sciences Ltd. | 10% Owner | Buy | 121,906 | $11.89 | $1,449,100.74 | +0.1% | → |